# Eli Lilly agrees to buy Curevo, LimmaTech Biologics and Vaccine Company.

*biotech · news · 2026-05-26 · CNBC*

## Key points

- Eli Lilly will acquire Curevo, LimmaTech Biologics, and Vaccine Company for nearly $4 billion total.
- The deals include $1.5 billion for Curevo, $780 million for LimmaTech Biologics, and $1.55 billion for Vaccine Company.
- These acquisitions mark a strategic expansion into infectious disease research and development for Eli Lilly.
- Eli Lilly shares increased by 1.3% in premarket trading following the acquisition announcements.

**Companies:** Eli Lilly, Curevo, LimmaTech Biologics, Vaccine Company

[Read the full story on CNBC](https://www.cnbc.com/2026/05/26/eli-lilly-stock-vaccine-deals-curevo-limmatech.html)

---

Canonical: https://newsio.io/n/3922c77c-45aa-4a8c-a1ee-793e5ce8fc49/eli-lilly-agrees-to-buy-curevo-limmatech-biologics-and-vaccine-company-the-compa
Summarized by Newsio from CNBC. https://newsio.io/how-it-works